A Multicenter, Open-Label, Two-Arm Prospective Study to Evaluate the Impact of Patient Readiness to Self-Inject on Outcomes When Using the Copaxone® Prefilled Syringes [The "READY" Trial]

Teva Neuroscience, Inc.0 个研究点目标入组 257 人开始时间: 2003年5月最近更新: 2011年4月12日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Teva Neuroscience, Inc.
入组人数: 257
主要终点: Adherence of self-injection assessed by self-report at each follow-up visit

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

This study has patients responding to two sets of surveys that will tell their doctor or nurse about their readiness to begin self-injection. In addition, patients will have their self-injection observed and evaluated on up to three visits

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Male or Female, 18 years of age or older, with diagnosis of RRMS
•Naive to treatment or previously treated with an IFN.

排除标准

•Not eligible for treatment based on clinical criteria and current indication.
•Unable to respond to surveys or provide informed consent.

结局指标

主要结局

Adherence of self-injection assessed by self-report at each follow-up visit

时间窗: 12 months

次要结局

未报告次要终点

研究者

发起方

Teva Neuroscience, Inc.

申办方类型

Industry

相似试验

已完成

4 期

A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.Post Menopausal Osteoporosis

NCT00377234Hoffmann-La Roche356

已完成

2 期

Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys BullosaEPIDERMOLYSIS BULLOSA

NCT00987142Tigenix S.A.U.12

已完成

1 期

A Study to Compare Pharmacokinetics (PK) of Etrolizumab Administered Subcutaneously by a Prefilled Syringe With Needle Safety Device (PFS-NSD) or an Auto-injector (AI)Healthy Volunteers

NCT02996019Genentech, Inc.180

已完成

2 期

Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple MyelomaMultiple Myeloma

NCT00065351Celgene222

已完成

3 期

Tezepelumab Home Use StudyAsthma

NCT03968978AstraZeneca216